| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP)
|
Camps Herrero, C.
|
|
2018
|
21 |
3 |
p. 380-390
|
artikel
|
| 2 |
Baseline 18F-Fluorocholine PET/CT and bone scan in the outcome prediction of patients treated with radium 223 dichloride
|
García Vicente, A. M.
|
|
2018
|
21 |
3 |
p. 289-297
|
artikel
|
| 3 |
Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder
|
El Rassy, E.
|
|
2018
|
21 |
3 |
p. 280-288
|
artikel
|
| 4 |
Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer
|
Anido-Herranz, U.
|
|
2018
|
21 |
3 |
p. 249-258
|
artikel
|
| 5 |
Classical Protein Kinase C: a novel kinase target in breast cancer
|
Singh, R. K.
|
|
2018
|
21 |
3 |
p. 259-267
|
artikel
|
| 6 |
Differences on metabolic behavior between intra and extrahepatic cholangiocarcinomas at 18F-FDG–PET/CT: prognostic implication of metabolic parameters and tumor markers
|
Sabaté-Llobera, A.
|
|
2018
|
21 |
3 |
p. 324-333
|
artikel
|
| 7 |
Effectiveness, safety and cost of abiraterone acetate in patients with metastatic castration-resistant prostate cancer: a real-world data analysis
|
Koninckx, M.
|
|
2018
|
21 |
3 |
p. 314-323
|
artikel
|
| 8 |
Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancers
|
Chung, V.
|
|
|
21 |
3 |
p. 363-372
|
artikel
|
| 9 |
Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancers
|
Chung, V.
|
|
2018
|
21 |
3 |
p. 363-372
|
artikel
|
| 10 |
Lung cancer patients with a previous extra-pulmonary malignancy should not be considered homogeneous: a clinicopathological analysis of 3530 surgical cases
|
Hu, X.-L.
|
|
2018
|
21 |
3 |
p. 348-354
|
artikel
|
| 11 |
Measurement of circulating tumor cells in squamous cell carcinoma of the head and neck and patient outcomes
|
Morgan, T. M.
|
|
2018
|
21 |
3 |
p. 342-347
|
artikel
|
| 12 |
Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
|
Farhood, B.
|
|
2018
|
21 |
3 |
p. 268-279
|
artikel
|
| 13 |
Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival
|
Casas, F.
|
|
2018
|
21 |
3 |
p. 355-362
|
artikel
|
| 14 |
Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival
|
Casas, F.
|
|
|
21 |
3 |
p. 355-362
|
artikel
|
| 15 |
Prognostic implication of EGFR mutation status and subtype in resected lung adenocarcinoma patients irrespective of therapy
|
Li, R.
|
|
2018
|
21 |
3 |
p. 298-303
|
artikel
|
| 16 |
Retroperitoneal fibrosis secondary to non-urology carcinomas: a clinical and outcome analysis of 97 cases
|
Chen, T.
|
|
2018
|
21 |
3 |
p. 373-379
|
artikel
|
| 17 |
The Medical Oncology resident mentor: situation and workload
|
Elez, E.
|
|
2018
|
21 |
3 |
p. 304-313
|
artikel
|
| 18 |
TIPE1 suppresses osteosarcoma tumor growth by regulating macrophage infiltration
|
Chen, P.
|
|
2018
|
21 |
3 |
p. 334-341
|
artikel
|
Tijdschrift beschrijving